News Focus
News Focus
icon url

oldmusky

06/28/18 9:24 AM

#84625 RE: Brian903 #84623

Now I do not think the great Dr Lohr would be discussing the trial design if he did not plan to execute the trial.

He said success is not guaranteed but then stated several reasons why it should be more statistically significant than the last trial.

PMCB is primed for 2b trial with FDA.

Longs will soon be rewarded.
icon url

1234jklm

06/28/18 9:39 AM

#84631 RE: Brian903 #84623

Excellent interview with Professor Dr Lohr

An improved technology will bring improved results.

The trial design sounds impressive and likely to serve the trials well.

We have such brilliant men working with us.
icon url

hockeypond

06/28/18 11:22 AM

#84643 RE: Brian903 #84623

In the interview he talks about in earlier clinical trails 1/2? Has Pharmacycte had earlier trials with the FDA and did not pass the trials?